Foghorn Therapeutics Inc.

NasdaqGM:FHTX Stock Report

Mkt Cap: US$267.3m

Foghorn Therapeutics Future Growth

Future criteria checks 2/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Foghorn Therapeutics.

Key information

7.4%

Earnings growth rate

16.1%

EPS growth rate

Biotechs earnings growth22.4%
Revenue growth rate50.0%
Future return on equityn/a
Analyst coverage

Good

Last updated09 May 2023

Recent future growth updates

Recent updates

Foghorn Therapeutics: Selling For Less Than Cash Value

Oct 10

Foghorn stock slumps 18% as FDA places full clinical hold on blood cancer trial of FHD-286

Aug 23

Foghorn Therapeutics GAAP EPS of -$0.66 misses by $0.07, revenue of $4.49M

Aug 09

Foghorn: Big Pharma Interest, Resolvable Clinical Hold Equals Opportunity

Jun 02

We're Hopeful That Foghorn Therapeutics (NASDAQ:FHTX) Will Use Its Cash Wisely

Apr 13
We're Hopeful That Foghorn Therapeutics (NASDAQ:FHTX) Will Use Its Cash Wisely

Are Insiders Buying Foghorn Therapeutics Inc. (NASDAQ:FHTX) Stock?

Feb 27
Are Insiders Buying Foghorn Therapeutics Inc. (NASDAQ:FHTX) Stock?

Earnings and Revenue Growth Forecasts

NasdaqGM:FHTX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202540-166-174N/A4
12/31/202435-147-146N/A7
12/31/202323-131-127N/A7
3/31/2020N/A-54-48-47N/A
12/31/2019N/A-51-47-46N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: FHTX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: FHTX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: FHTX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: FHTX's revenue (50% per year) is forecast to grow faster than the US market (8% per year).

High Growth Revenue: FHTX's revenue (50% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if FHTX's Return on Equity is forecast to be high in 3 years time


Discover growth companies